ELI LILLY & Co (LLY) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-06 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: ELI LILLY & Co (LLY) CIK: 0000059478 --- Reporting Owner --- Name: LILLY ENDOWMENT INC CIK: 0000316011 Role: Other (Former 10% Shareholder) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-06 | Code: S (Open market sale) Shares: -13,620 | Price: $995.23 Total Value: $13,554,964.50 Shares Owned After: 91,883,358 | Ownership: D (Direct) Footnotes: [F1] The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. [Transaction #2] Security: Common Stock Date: 2026-05-06 | Code: S (Open market sale) Shares: -2,208 | Price: $996.18 Total Value: $2,199,572.06 Shares Owned After: 91,881,150 | Ownership: D (Direct) Footnotes: [F2] The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. --- Footnotes (Complete Index) --- F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. --- Signature --- /s/ /s/ Diane M. Stenson, Vice President and Treasurer, on behalf of Lilly Endowment Inc. (2026-05-07)